Evidence map›Paper›PMID 24686885›Full record

Trial reportThe British journal of general practice : the journal of the Royal College of General Practitioners2014

Change in cardiovascular risk factors following early diagnosis of type 2 diabetes: a cohort analysis of a cluster-randomised trial.

James A Black, Stephen J Sharp, Nicholas J Wareham, Annelli Sandbæk, Guy E H M Rutten, Torsten Lauritzen, Kamlesh Khunti, Melanie J Davies, Knut Borch-Johnsen, Simon J Griffin and 1 more

Open access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The British journal of general practice : the journal of the Royal College of General Practitioners, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Comparing the utility of the non-mydriatic fundus camera to the direct ophthalmoscope for medical education.Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health · 2015
    Article
  9. Article
  10. Article
  11. Assessing, communicating, and managing risk in general practice.The British journal of general practice : the journal of the Royal College of General Practitioners · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

James A BlackMRC Epidemiology Unit, Addenbrooke's Hospital, Cambridge.
Stephen J Sharp
Nicholas J Wareham
Annelli Sandbæk
Guy E H M Rutten
Torsten Lauritzen
Kamlesh Khunti
Melanie J Davies
Knut Borch-Johnsen
Simon J Griffin
Rebecca K Simmons
Aarhus University · DKUniversity Medical Center Utrecht · NL

Funding

Department of Health 08/116/300Department of Health RP-PG-0606-1259Medical Research Council G0001164Medical Research Council MC_U106179471Medical Research Council MC_U106179474Medical Research Council MC_UU_12015/1Medical Research Council MC_UU_12015/4
6 · The paper itself

Abstract

backgroundThere is little evidence to inform the targeted treatment of individuals found early in the diabetes disease trajectory.

aimTo describe cardiovascular disease (CVD) risk profiles and treatment of individual CVD risk factors by modelled CVD risk at diagnosis; changes in treatment, modelled CVD risk, and CVD risk factors in the 5 years following diagnosis; and how these are patterned by socioeconomic status. DESIGN AND

settingCohort analysis of a cluster-randomised trial (ADDITION-Europe) in general practices in Denmark, England, and the Netherlands.

methodA total of 2418 individuals with screen-detected diabetes were divided into quartiles of modelled 10-year CVD risk at diagnosis. Changes in treatment, modelled CVD risk, and CVD risk factors were assessed at 5 years.

resultsThe largest reductions in risk factors and modelled CVD risk were seen in participants who were in the highest quartile of modelled risk at baseline, suggesting that treatment was offered appropriately. Participants in the lowest quartile of risk at baseline had very similar levels of modelled CVD risk at 5 years and showed the least variation in change in modelled risk. No association was found between socioeconomic status and changes in CVD risk factors, suggesting that treatment was equitable.

conclusionDiabetes management requires setting of individualised attainable targets. This analysis provides a reference point for patients, clinicians, and policymakers when considering goals for changes in risk factors early in the course of the disease that account for the diverse cardiometabolic profile present in individuals who are newly diagnosed with type 2 diabetes.

Indexed as

BiomarkersBody Mass IndexCardiovascular DiseasesCholesterol, HDLCluster AnalysisCohort StudiesCreatinineDenmarkDiabetes Mellitus, Type 2Early DiagnosisEnglandFemaleFollow-Up StudiesGlycated HemoglobinHumansHypoglycemic AgentsBiomarkersCholesterol, HDLCreatinineGlycated HemoglobinHypoglycemic AgentsSerum AlbuminTriglyceridescardiovascular diseasesdiabetes mellitus, type 2prevention and controlprimary health carerisk assessmentrisk factorstreatment heterogeneity

Identifiers

PMID24686885
PMCPMC3964458
OpenAlexW2142597437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.